Monday, June 25, 2007: 2:45 PM-3:45 PM
B3: Lipid Management in Women: Beyond LDL  
Suzanne Hughes
  • Define the gender differences in the impact of elevated triglycerides and low HDL on CVD risk.
  • Summarize the clinical trial evidence that LDL-C reduction is associated with clinical benefit in women.
  • Outline the lifestyle and pharmacologic strategies to employ in women with elevated non-HDL-C who are on maximal therapy for LDL-C reduction.
  • See more of The Association of Women's Health, Obstetric and Neonatal Nurses (June 23-27, 2007)